ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
알레르기 면역치료 시장 규모는 2025년 20억 5,000만 달러에서 2034년에는 45억 7,000만 달러에 이를 것으로 예측되며, 2026-2034년 CAGR 9.28%로 성장할 전망입니다.
세계적으로 알레르기 질환의 유병률이 지속적으로 증가함에 따라 알레르기 면역치료 시장은 괄목할 만한 성장이 예상되고 있습니다. 알레르기 관리에서 면역 요법의 장기적인 이점에 대한 인식이 높아짐에 따라 환자와 의료 서비스 제공업체 모두 이 치료 옵션에 대한 관심이 점점 더 높아지고 있습니다. 피하 또는 설하 투여와 같은 면역치료 기술의 발전이 시장을 주도하고 있으며, 기존 알레르기 치료법에 비해 더 효과적이고 환자 부담이 적은 옵션을 제공합니다. 알레르기 반응의 기저 메커니즘에 대한 연구가 진행됨에 따라, 표적치료제 개발이 치료 효과와 환자 순응도 향상에 기여할 것으로 기대됩니다.
기술 혁신은 알레르기 면역 치료 시장 전망을 형성하는 데 중요한 역할을 하고 있습니다. 개별 환자 프로파일에 맞게 치료를 조정하는 개인 맞춤형 의료 접근법이 통합되고 있습니다. 이러한 정밀의료로의 전환은 치료 결과의 향상과 부작용의 최소화를 기대할 수 있으며, 환자 만족도 향상으로 이어질 수 있을 것으로 보입니다. 또한, 생물학적 제제와 단일 클론 항체의 등장은 알레르기 치료의 지형을 바꾸고 심각한 알레르기 반응과 만성 질환 관리의 새로운 길을 열어주고 있습니다. 이러한 첨단 치료법이 규제 당국의 승인을 받음에 따라 채택이 가속화되어 시장 성장을 더욱 촉진할 것으로 예측됩니다.
또한, 알레르기 면역치료 시장은 예방의학 및 조기 개입 전략에 대한 관심이 높아짐에 따라 수혜를 받고 있습니다. 의료 시스템이 알레르기 관리에 있어 적극적인 접근 방식을 우선시함에 따라 면역 요법에 대한 수요는 증가할 것으로 예측됩니다. 환자들에게 면역치료의 이점에 대한 정보를 제공하는 것을 목표로 하는 대중 인식 개선 캠페인과 교육 이니셔티브도 시장 확대에 기여할 것입니다. 요약하면, 알레르기 면역치료 시장은 기술 발전, 맞춤 치료 접근법, 환자 결과 개선을 위한 공동의 노력에 힘입어 괄목할 만한 성장을 이룰 것으로 보입니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 알레르기 면역치료 시장 : 치료 유형별
제5장 세계의 알레르기 면역치료 시장 : 유형별
제6장 세계의 알레르기 면역치료 시장 : 알레르기 유형별
제7장 세계의 알레르기 면역치료 시장 : 유통 채널별
제8장 세계의 알레르기 면역치료 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
LSH
영문 목차
영문목차
The Allergy Immunotherapy Market size is expected to reach USD 4.57 Billion in 2034 from USD 2.05 Billion (2025) growing at a CAGR of 9.28% during 2026-2034.
The allergy immunotherapy market is set for remarkable growth as the prevalence of allergic conditions continues to rise globally. With increasing awareness of the long-term benefits of immunotherapy in managing allergies, patients and healthcare providers are increasingly turning to this treatment option. The market is being driven by advancements in immunotherapy techniques, including subcutaneous and sublingual methods, which offer more effective and patient-friendly alternatives to traditional allergy treatments. As research continues to unveil the underlying mechanisms of allergic responses, the development of targeted therapies is expected to enhance treatment efficacy and patient compliance.
Technological innovations are playing a crucial role in shaping the future of the allergy immunotherapy market. The integration of personalized medicine approaches, where treatments are tailored to individual patient profiles, is gaining traction. This shift towards precision medicine is expected to improve treatment outcomes and minimize adverse effects, thereby increasing patient satisfaction. Additionally, the emergence of biologics and monoclonal antibodies is revolutionizing the landscape of allergy treatment, providing new avenues for managing severe allergic reactions and chronic conditions. As these advanced therapies gain regulatory approval, their adoption is likely to accelerate, further propelling market growth.
Furthermore, the allergy immunotherapy market is benefiting from a growing emphasis on preventive healthcare and early intervention strategies. As healthcare systems prioritize proactive approaches to managing allergies, the demand for immunotherapy is expected to rise. Public awareness campaigns and educational initiatives aimed at informing patients about the benefits of immunotherapy will also contribute to market expansion. In summary, the allergy immunotherapy market is poised for significant growth, driven by technological advancements, personalized treatment approaches, and a collective commitment to improving patient outcomes.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Treatment Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
By Type
Tablets
Drops
By Allergy Type
Allergic Rhinitis
Allergic Asthma
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
COMPANIES PROFILED
DMK Pharmaceuticals, ALKAbell AS, Allergy Therapeutics, ASIT Biotech, Circassia, DVB Technologies SA, DESENTUM OY, HAL Allergy BV, HollisterStier Allergy, LETIPharma
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.4.1 Standards & Compliance
3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints
3.5.3 Market Opportunities
3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)
4.1. Market Analysis, Insights and Forecast Treatment Type
4.2. Subcutaneous Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Sublingual Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY TYPE 2022-2034 (USD MN)
5.1. Market Analysis, Insights and Forecast Type
5.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Drops Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY ALLERGY TYPE 2022-2034 (USD MN)
6.1. Market Analysis, Insights and Forecast Allergy Type
6.2. Allergic Rhinitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Allergic Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
7.1. Market Analysis, Insights and Forecast Distribution Channel
7.2. Hospital Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Retail Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Online Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET: BY REGION 2022-2034(USD MN)
8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.2.1 By Treatment Type
8.2.2 By Type
8.2.3 By Allergy Type
8.2.4 By Distribution Channel
8.2.5 United States
8.2.6 Canada
8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.3.1 By Treatment Type
8.3.2 By Type
8.3.3 By Allergy Type
8.3.4 By Distribution Channel
8.3.5 United Kingdom
8.3.6 France
8.3.7 Germany
8.3.8 Italy
8.3.9 Russia
8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.4.1 By Treatment Type
8.4.2 By Type
8.4.3 By Allergy Type
8.4.4 By Distribution Channel
8.4.5 India
8.4.6 Japan
8.4.7 South Korea
8.4.8 Australia
8.4.9 South East Asia
8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.5.1 By Treatment Type
8.5.2 By Type
8.5.3 By Allergy Type
8.5.4 By Distribution Channel
8.5.5 Brazil
8.5.6 Argentina
8.5.7 Peru
8.5.8 Chile
8.5.9 South East Asia
8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.6.1 By Treatment Type
8.6.2 By Type
8.6.3 By Allergy Type
8.6.4 By Distribution Channel
8.6.5 Saudi Arabia
8.6.6 UAE
8.6.7 Israel
8.6.8 South Africa
8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL ALLERGY IMMUNOTHERAPY INDUSTRY
